Discontinuation report NOVAHISTINE DH
| Report ID | 98377 |
| Drug Identification Number | 02049473 |
| Brand name | NOVAHISTINE DH |
| Common or Proper name | Novahistine DH |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE |
| Strength(s) | 10MG 1.7MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL |
| Packaging size | 100ml |
| ATC code | R05DA |
| ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-06-30 |
| Actual discontinuation date | 2020-07-10 |
| Remaining supply date | 2020-06-30 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | last lot 8115892 expiry 2021-10-17 |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-08-04 | French | Compare |
| v5 | 2020-08-04 | English | Compare |
| v4 | 2020-08-03 | French | Compare |
| v3 | 2020-08-03 | English | Compare |
| v2 | 2019-11-11 | French | Compare |
| v1 | 2019-11-11 | English | Compare |
Showing 1 to 6 of 6